Clinical trials

  • ISATUXIMAB for T-cell acute lymphoblastic leukemia | Relapsed/refractory T-cell acute lymphoblastic leukemia | CD38-positive T-cell acute lymphoblastic leukemia
  • Pembrolizumab for Non-small cell lung cancer
  • Risankizumab for Axial spondyloarthritis
  • RITUXIMAB for Marginal zone lymphoma|Extranodal marginal zone lymphoma (MALT lymphoma)|Splenic marginal zone lymphoma|Nodal marginal zone lymphoma
  • PEMBROLIZUMAB for MSI-H/dMMR gastric cancer|MSI-H/dMMR gastroesophageal-junction cancer
  • PIRTOBRUTINIB for Chronic lymphocytic leukemia | Small lymphocytic lymphoma
  • MODIFIED VACCINIA ANKARA – BAVARIAN NORDIC LIVE VIRUS for Mpox infection
  • TIMREPIGENE EMPARVOVEC for Choroideremia | X-linked retinitis pigmentosa
  • VANCOMYCIN for Infective endocarditis
  • TREOSULFAN for Acute myeloid leukemia|Myelodysplastic syndrome
  • Obefazimod for Moderate to severe ulcerative colitis
  • Clinical trial in Breast cancer